180 Life Sciences Corp.
ATNF
Price:
$1.83
Market Cap:
$1.88M
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, Cali...[Read more]
Industry
Biotechnology
IPO Date
2017-06-27
Stock Exchange
NASDAQ
Ticker
ATNF
The ROE as of September 2024 (TTM) for 180 Life Sciences Corp. (ATNF) is 3.04%
According to 180 Life Sciences Corp.’s latest financial reports and current stock price. The company's current ROE is 3.04%. This represents a change of 53.24% compared to the average of 1.99% of the last 4 quarters.
180 Life Sciences Corp. (ATNF) Historical ROE (quarterly & annually)
How has ATNF ROE performed in the past?
The mean historical ROE of 180 Life Sciences Corp. over the last ten years is 2.19%. The current 3.04% ROE has changed 39.25% with respect to the historical average. Over the past ten years (40 quarters), ATNF's ROE was at its highest in in the September 2023 quarter at 6.87%. The ROE was at its lowest in in the June 2021 quarter at -863.68%.
Average
2.19%
Median
-39.64%
Minimum
-341.38%
Maximum
15.61%
180 Life Sciences Corp. (ATNF) ROE by Quarter and Year
Discovering the peaks and valleys of 180 Life Sciences Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 7.53%
Maximum Annual ROE = 15.61%
Minimum Annual Increase = -4671.65%
Minimum Annual ROE = -341.38%
| Year | ROE | Change |
|---|---|---|
| 2023 | 15.61% | -4671.65% |
| 2022 | -341.38% | 560.48% |
| 2021 | -51.69% | 30.38% |
| 2020 | -39.64% | -39.79% |
| 2019 | -65.84% | -134.87% |
| 2018 | 188.82% | 7.53% |
180 Life Sciences Corp. (ATNF) Average ROE
How has ATNF ROE performed in the past?
The current ROE of 180 Life Sciences Corp. (ATNF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
5.07%
5-year avg
3.02%
10-year avg
2.19%
180 Life Sciences Corp. (ATNF) ROE vs. Peers
How is ATNF’s ROE compared to its peers?
180 Life Sciences Corp.’s ROE is greater than Zura Bio Limited (-35.45%), greater than Phio Pharmaceuticals Corp. (-142.68%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), greater than Cardio Diagnostics Holdings, Inc. (-308.99%), greater than Altamira Therapeutics Ltd. (-233.96%), greater than Immix Biopharma, Inc. (-86.48%), greater than Enveric Biosciences, Inc. (-234.16%), greater than Palisade Bio, Inc. (-124.86%), less than CNS Pharmaceuticals, Inc. (428.91%), less than eFFECTOR Therapeutics, Inc. (2.18%), greater than Navidea Biopharmaceuticals, Inc. (-63.06%), greater than ZyVersa Therapeutics, Inc. (-172.51%), greater than Apexigen, Inc. (-606.56%),
| Company | ROE | Market cap |
|---|---|---|
| -35.45% | $230.22M | |
| -142.68% | $2.80M | |
| -398.33% | $4.50M | |
| -308.99% | $6.77M | |
| -233.96% | $1.66M | |
| -86.48% | $50.78M | |
| -234.16% | $4.46M | |
| -124.86% | $4.72M | |
| 428.91% | $4.76M | |
| 2.18% | $223.46K | |
| -63.06% | $100.08K | |
| -172.51% | $2.54M | |
| -606.56% | $9.57M |
Build a custom stock screener for 180 Life Sciences Corp. (ATNF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like 180 Life Sciences Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
180 Life Sciences Corp. (ATNF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like 180 Life Sciences Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is 180 Life Sciences Corp.'s ROE?
How is the ROE calculated for 180 Life Sciences Corp. (ATNF)?
What is the highest ROE for 180 Life Sciences Corp. (ATNF)?
What is the 3-year average ROE for 180 Life Sciences Corp. (ATNF)?
What is the 5-year average ROE for 180 Life Sciences Corp. (ATNF)?
How does the current ROE for 180 Life Sciences Corp. (ATNF) compare to its historical average?